Oxford Nanopore Technologies plc (FRA:4R0)

Market Cap	1.73B +3.1%
Revenue (ttm)	238.79M +22.0%
Net Income	-167.16M
EPS	-0.18
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	601
Open	1.754
Previous Close	1.810
Day's Range	1.754 - 1.786
52-Week Range	1.056 - 2.570
Beta	n/a
RSI	53.72
Earnings Date	Mar 2, 2026

About FRA:4R0

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its cu...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Employees: 1,325
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4R0

Financial Performance

In 2024, FRA:4R0's revenue was 183.19 million, an increase of 7.97% compared to the previous year's 169.67 million. Losses were -146.19 million, -5.38% less than in 2023.

Financial numbers in GBP